Nonselective and Cyclooxygenase-2-Selective NSAIDs and Acute Kidney Injury

American Journal of Medicine

Volumn 121, Issue 12, 2008, Pages 1092-1098

  Winkelmayer, Wolfgang C ^a   Waikar, Sushrut S ^a   Mogun, Helen ^a   Solomon, Daniel H ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acute renal failure; Adverse event; NSAID; Pharmacoepidemiology

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOROLAC; MELOXICAM; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; ROFECOXIB; SULINDAC; VALDECOXIB;

ADULT; ANALGESIA; ARTICLE; DRUG SAFETY; DRUG SELECTIVITY; FEMALE; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRESCRIPTION; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COHORT STUDIES; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; HOSPITALIZATION; HUMANS; KIDNEY DISEASES; MALE; RISK FACTORS; TIME FACTORS;

EID: 56349137174     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.06.035     Document Type: Article

References (18)

1. Curhan G.C., Bullock A.J., Hankinson S.E., et al. Frequency of use of acetaminophen, nonsteroidal anti-inflammatory drugs, and aspirin in US women. Pharmacoepidemiol Drug Saf 11 (2002) 687-693
2. Sturmer T., Erb A., Keller F., et al. Determinants of impaired renal function with use of nonsteroidal anti-inflammatory drugs: the importance of half-life and other medications. Am J Med 111 (2001) 521-527
3. Curhan G.C., Knight E.L., Rosner B., et al. Lifetime nonnarcotic analgesic use and decline in renal function in women. Arch Intern Med 164 (2004) 1519-1524
4. Griffin M.R., Yared A., and Ray W.A. Nonsteroidal antiinflammatory drugs and acute renal failure in elderly persons. Am J Epidemiol 151 (2000) 488-496
5. Perez Gutthann S., Garcia Rodriguez L.A., Raiford D.S., et al. Nonsteroidal anti-inflammatory drugs and the risk of hospitalization for acute renal failure. Arch Intern Med 156 (1996) 2433-2439
6. Huerta C., Castellsague J., Varas-Lorenzo C., and Garcia Rodriguez L.A. Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. Am J Kidney Dis 45 (2005) 531-539
7. Evans J.M., McGregor E., McMahon A.D., et al. Non-steroidal anti-inflammatory drugs and hospitalization for acute renal failure. QJM 88 (1995) 551-557
8. Schneider V., Levesque L.E., Zhang B., et al. Association of selective and conventional nonsteroidal antiinflammatory drugs with acute renal failure: a population-based, nested case-control analysis. Am J Epidemiol 164 (2006) 881-889
9. Solomon D.H., Avorn J., Sturmer T., et al. Cardiovascular outcomes in new users of coxibs and nonsteroidal antiinflammatory drugs: high-risk subgroups and time course of risk. Arthritis Rheum 54 (2006) 1378-1389
10. Waikar S.S., Wald R., Chertow G.M., et al. Validity of International Classification of Diseases, Ninth Revision, Clinical Modification Codes for Acute Renal Failure. J Am Soc Nephrol 17 (2006) 1688-1694
11. Localio A.R., Berlin J.A., Ten Have T.R., and Kimmel S.E. Adjustments for center in multicenter studies: an overview. Ann Intern Med 135 (2001) 112-123
12. Rothman K.J. No adjustments are needed for multiple comparisons. Epidemiology 1 (1990) 43-46
13. Lagakos S.W. The challenge of subgroup analyses-reporting without distorting. N Engl J Med 354 (2006) 1667-1669
14. Kieszak S.M., Flanders W.D., Kosinski A.S., et al. A comparison of the Charlson comorbidity index derived from medical record data and administrative billing data. J Clin Epidemiol 52 (1999) 137-142
15. Humphries K.H., Rankin J.M., Carere R.G., et al. Co-morbidity data in outcomes research: are clinical data derived from administrative databases a reliable alternative to chart review?. J Clin Epidemiol 53 (2000) 343-349
16. Whelton A., Lefkowith J.L., West C.R., and Verburg K.M. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen. Kidney Int 70 (2006) 1495-1502
17. Zhang J., Ding E.L., and Song Y. Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials. JAMA 296 (2006) 1619-1632
18. Hermann M., and Luscher T.F. Are there differences in the renal effects of selective cyclo-oxygenase 2 inhibitors?. Nat Clin Pract Nephrol 2 (2006) 174-175